RCRecallCheck

Brand entity

Omerta ®

Results are official records from named sources. Coverage is incomplete. This site is not medical advice and does not publish drug labels, openFDA, Prop 65 or NIH DSLD records.

No Wikidata QID is asserted for this brand in the current slice.

What the governed recall projection contains

This page groups 3 official recall actions that explicitly name Omerta ®. They come from safety-gate (3).

The published dates in this group run from 2026-03-13 to 2026-03-13. The projection was retrieved 2026-09-04T21:09:13.297Z; dates describe the notices, not whether every affected unit has been repaired.

2 distinct published hazard statements are represented. Open each action for its hazard, remedy, jurisdiction, native identifier and official source link. Similar brand names are not merged unless the source record names the brand.

safety-gate2026-03-13SR/00703/26

Omerta ® — Perfume — EAU DE PARFUM UNTRUE LIES FRAGILE

According to the list of ingredients, the product contains 2-(4-tert-butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products. BMHCA may harm the reproductive system, may harm the health of the unborn child and may cause skin sensitisation. The product does not comply with the Cosmetic Products Regulation.

Published remedy: Type of economic operator to whom the measure(s) were ordered: DistributorCategory of measure(s): Withdrawal of the product from the marketDate of entry into force: 25/02/2026

safety-gate2026-03-13SR/00709/26

Omerta ® — Perfume — EAU DE PARFUM Butterfly

According to the list of ingredients the product contains 2-(4-tert- butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products. BMHCA may harm the reproductive system, may harm the health of the unborn child and may cause skin sensitisation. The product does not comply with the Cosmetic Products Regulation.

Published remedy: Type of economic operator to whom the measure(s) were ordered: DistributorCategory of measure(s): Withdrawal of the product from the marketDate of entry into force: 25/02/2026

safety-gate2026-03-13SR/00716/26

Omerta ® — Perfume — Butterfly

According to the list of ingredients the product contains 2-(4-tert- butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products. BMHCA may harm the reproductive system, may harm the health of the unborn child and may cause skin sensitisation. The product does not comply with the Cosmetic Products Regulation.

Published remedy: Type of economic operator to whom the measure(s) were ordered: DistributorCategory of measure(s): Withdrawal of the product from the marketDate of entry into force: 25/02/2026